Senator Elizabeth Warren (D-MA) has expressed strong support for the White House's recent warning to pharmaceutical companies, raising the possibility of revoking patent protection for drugs developed with taxpayer funding if prices are deemed too high.
Warren, a vocal advocate for affordable healthcare, praised the administration's action, calling it "a critical step in lowering the high cost of prescription drugs for American families." She emphasized the need for accountability, stating, "It's unacceptable that pharmaceutical companies are gouging Americans on drugs that were developed with taxpayer support."
The senator anticipates strong resistance from the pharmaceutical industry, stating. . .